Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ARV-766 |
| Trade Name | |
| Synonyms | ARV 766|ARV766|Luxdegalutamide|JSB462 |
| Drug Descriptions |
ARV-766 is a proteolysis-targeted chimera (PROTAC) that induces degradation of wild-type androgen receptor (AR) and AR ligand-binding domain mutants, which potentially results in antitumor activity (J Clin Oncol 2024 42:16_suppl, 5011). |
| DrugClasses | Hormone - Anti-androgens 57 |
| CAS Registry Number | 2750830-09-0 |
| NCIT ID | C183151 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Abiraterone + ARV-766 | ARV-766 Abiraterone | 0 | 1 |
| ARV-766 | ARV-766 | 0 | 0 |
| ARV-766 + lutetium Lu 177 vipivotide tetraxetan | ARV-766 lutetium Lu 177 vipivotide tetraxetan | 0 | 1 |
| ARV-766 + Tulmimetostat | ARV-766 Tulmimetostat | 0 | 1 |